Five Star Equities Provides Stock Research on Neuralstem and Cyclacel Pharmaceuticals
Continue ReadingTag: equity-research
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on StemCells and Aastrom Biosciences
Continue ReadingSpecial Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase
Five Star Equities Provides Stock Research on Health Care REIT and R.R. Donnelley & Sons
Continue ReadingEthanol Stocks Struggle as E15 Fuel Fails to Gain Widespread Adoption
The Paragon Report Provides Stock Research on Green Plains Renewable Energy and Renewable Energy Group
Continue ReadingRecent AAA Survey Shows Just 5% Cars and Trucks in the U.S. Approved to Use E15 Fuel
The Paragon Report Provides Stock Research on BioFuel Energy and Pacific Ethanol
Continue ReadingThe Amount of Companies Paying Special Dividends in 2012 Is Four Times the Pace of 2011
Five Star Equities Provides Stock Research on Verizon and CenturyLink
Continue ReadingNatural Gas Heating Demand Expected to Be 34% Below Average in the Coming Weeks
The Paragon Report Provides Stock Research on EnCana and Cheniere Energy
Continue ReadingNumber of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms
Five Star Equities Provides Stock Research on Lockheed Martin and Pitney Bowes
Continue ReadingForecasts for Warmer Temperatures and Lower Heating Demand Causes Natural Gas Prices to Fall Sharply
The Paragon Report Provides Stock Research on Devon Energy and Quicksilver Resources
Continue ReadingU.S. Foreign Oil Imports Projected to Decline by More than 50% Within the Next Decade
The Paragon Report Provides Stock Research on Lucas Energy and Triangle Petroleum
Continue Reading